HRMY
$38.70+3.09%
Harmony Biosciences Holdings Inc.Stock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
HRMY financial statements
The full income statement, balance sheet, and cash-flow statement for Harmony Biosciences Holdings Inc. (HRMY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 56.8M2024-09 57.0M2024-12 57.3M2025-03 57.4M2025-06 57.5M2025-09 57.6M2025-12 57.8M2026-03 57.9M2026-06 58.2M+2.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 868M+21.5% | 715M+22.8% | 582M+32.9% | 438M+43.4% | 305M+91.2% | |
| 670M+20.1% | 558M+21.1% | 461M+30.0% | 354M+41.8% | 250M+89.3% | ||
| Cost of revenue | 198M+26.5% | 157M+29.3% | 121M+45.2% | 83.5M+50.4% | 55.5M+100.2% | |
| 462M+25.8% | 367M+36.6% | 269M+14.8% | 234M+44.2% | 162M+41.2% | ||
| Research & development | 190M+30.0% | 146M+91.7% | 76.1M+7.3% | 70.9M+133.4% | 30.4M+56.1% | |
| Selling, general & administrative | 153M+38.2% | 110M+15.8% | 95.3M+13.4% | 84.0M+31.5% | 63.9M+60.8% | |
| General & administrative | 153M+38.2% | 110M+15.8% | 95.3M+13.4% | 84.0M+31.5% | 63.9M+60.8% | |
| Selling & marketing | 120M+7.8% | 111M+13.9% | 97.4M+22.9% | 79.3M+16.4% | 68.1M+22.0% | |
| Amortization of intangibles | 23.8M+0.0% | 23.8M+0.0% | 23.8M+3.8% | 23.0M+24.7% | 18.4M+87.2% | |
| Operating income | 208M+9.2% | 191M-0.6% | 192M+59.8% | 120M+37.3% | 87.5M+415.3% | |
| Interest expense | 14.6M-16.3% | 17.5M-26.4% | 23.8M+26.4% | 18.8M-22.3% | 24.2M-15.4% | |
| Other non-operating income | -680K-900.0% | -68.0K-142.8% | 159K-5.9% | 169K+956.3% | 16.0K+100.5% | |
| Pre-tax income | 215M+12.1% | 192M+10.6% | 173M+65.6% | 105M+179.7% | 37.4M+201.3% | |
| Income tax | 56.4M+21.7% | 46.3M+4.0% | 44.5M+158.0% | -76.8M-2812.2% | 2.83M | |
| 159M+9.1% | 145M+12.9% | 129M-29.0% | 181M+424.5% | 34.6M+193.6% | ||
| Net income to common | — | — | 129M-29.0% | 181M+424.5% | 34.6M+154.2% | |
| $2.71+8.0% | $2.51+17.8% | $2.13-28.3% | $2.97+412.1% | $0.58+123.4% | ||
| EPS (basic) | $2.76+7.8% | $2.56+18.0% | $2.17-29.3% | $3.07+411.7% | $0.60+124.2% | |
| Weighted-avg shares (basic) | 57.5M+1.1% | 56.9M-4.3% | 59.5M+0.5% | 59.2M+2.9% | 57.5M+123.2% | |
| Weighted-avg shares (diluted) | 58.5M+1.2% | 57.9M-4.1% | 60.4M-1.2% | 61.1M+3.2% | 59.2M+129.7% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 907M+56.6% | 579M+28.4% | 451M+12.7% | 400M+40.7% | 284M+8.2% | ||
| Cash & equivalents | 753M+66.1% | 453M+45.4% | 312M+27.8% | 244M+4.0% | 234M+2.5% | |
| Short-term investments | 22.8M+61.0% | 14.2M-66.1% | 41.8M-47.3% | 79.3M | — | |
| Accounts receivable | 96.8M+16.6% | 83.0M+12.0% | 74.1M+35.4% | 54.7M+57.1% | 34.8M+57.1% | |
| Inventory | 5.36M-25.6% | 7.20M+34.2% | 5.36M+24.8% | 4.30M-3.0% | 4.43M+15.9% | |
| Prepaid expenses | 16.0M+16.8% | 13.7M+9.1% | 12.6M+34.5% | 9.35M+22.4% | 7.64M+9.7% | |
| Other current assets | 13.5M+66.4% | 8.12M+46.7% | 5.54M-37.0% | 8.79M+173.0% | 3.22M+147.2% | |
| 1.27B+27.3% | 999M+23.1% | 811M+20.4% | 674M+55.5% | 433M+1.5% | ||
| Property, plant & equipment | — | 1.26M+238.8% | 371K-35.3% | 573K-30.1% | 820K-12.6% | |
| Operating lease right-of-use | 5.34M+151.8% | 2.12M-9.5% | 2.34M+1.4% | 2.31M-29.9% | 3.30M | |
| Intangible assets | 89.4M-21.1% | 113M-17.4% | 137M-14.8% | 161M+11.8% | 144M-11.3% | |
| Long-term investments | 107M-1.6% | 109M+50.9% | 72.2M+219.8% | 22.6M | — | |
| Deferred tax assets | 150M-21.4% | 190M+32.1% | 144M+67.7% | 85.9M | — | |
| Other non-current assets | 18.4M+147.8% | 7.41M+17.7% | 6.30M+125.1% | 2.80M-20.4% | 3.52M+2212.5% | |
| Total non-current assets | 365M-13.2% | 420M+16.5% | 360M+31.7% | 274M+83.6% | 149M-9.2% | |
| 252M+44.0% | 175M+6.9% | 164M+107.6% | 78.9M+46.7% | 53.8M-60.0% | ||
| Accounts payable | 17.7M+28.7% | 13.7M-22.5% | 17.7M+368.3% | 3.79M+278.2% | 1.00M-60.8% | |
| Accrued liabilities | 191M+58.4% | 121M+21.3% | 99.5M+66.0% | 59.9M+48.9% | 40.2M-67.2% | |
| Short-term & current debt | 20.0M+23.1% | 16.3M+8.3% | 15.0M+650.0% | 2.00M+0.0% | 2.00M | |
| Current lease liability | 1.07M-18.6% | 1.32M-8.3% | 1.44M-11.0% | 1.61M+5.7% | 1.53M | |
| Other current liabilities | 4.96M-12.6% | 5.67M-27.4% | 7.81M+380.9% | 1.62M+19.4% | 1.36M+333.1% | |
| 401M+18.0% | 340M-1.3% | 344M+27.1% | 271M+9.8% | 247M-25.1% | ||
| Long-term debt | 144M-11.9% | 163M-8.7% | 179M-5.8% | 190M-0.2% | 190M-2.2% | |
| Non-current lease liability | 4.51M+448.9% | 822K-24.0% | 1.08M+11.0% | 975K-56.3% | 2.23M | |
| Operating lease liability (total) | 5.58M+161.0% | 2.14M-15.0% | 2.52M-2.7% | 2.59M-31.1% | 3.76M | |
| Other non-current liabilities | 5.62M+188.5% | 1.95M-7.7% | 2.11M-15.7% | 2.50M-21.3% | 3.18M+187.5% | |
| Total non-current liabilities | 149M-9.5% | 165M-8.7% | 181M-6.0% | 192M-0.5% | 193M-1.1% | |
| 870M+32.0% | 659M+41.1% | 467M+15.9% | 403M+116.0% | 187M+91.9% | ||
| Common stock | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | 1.00K+0.0% | |
| Additional paid-in capital | 709M+7.9% | 657M+7.6% | 610M-9.6% | 675M+5.5% | 640M+9.3% | |
| Retained earnings | 161M+7161.0% | 2.22M+101.5% | -143M+47.3% | -272M+40.0% | -454M+7.1% | |
| Accumulated other comprehensive income | 346K+424.2% | 66.0K+3200.0% | 2.00K+101.3% | -151K | — | |
| Total liabilities & equity | 1.27B+27.3% | 999M+23.1% | 811M+20.4% | 674M+55.5% | 433M+1.5% | |
| Common shares issued | 57.7M+1.0% | 57.1M+0.7% | 56.8M-4.8% | 59.6M+1.3% | 58.8M+3.4% | |
| Common shares outstanding | 57.7M+1.0% | 57.1M+0.7% | 56.8M-4.8% | 59.6M+1.3% | 58.8M+3.4% | |
| Shares outstanding (cover) | 57.8M+0.9% | 57.3M+1.0% | 56.8M-4.8% | 59.6M+1.3% | 58.9M+3.5% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 348M+58.4% | 220M+0.2% | 219M+51.9% | 144M+46.6% | 98.6M+3401.7% | ||
| Depreciation & amortization | — | 24.1M-1.0% | 24.4M+4.2% | 23.4M+24.1% | 18.8M+84.0% | |
| Intangible amortization | 23.8M+0.0% | 23.8M+0.0% | 23.8M+3.8% | 23.0M+24.7% | 18.4M+87.2% | |
| Share-based compensation | 44.9M+5.4% | 42.6M+34.4% | 31.7M+21.1% | 26.2M+67.1% | 15.7M+233.7% | |
| Deferred income taxes | 40.7M+245.4% | -28.0M-108.7% | -13.4M-228.7% | 10.4M+60.2% | 6.51M+393.4% | |
| Change in receivables | 13.8M+54.7% | 8.89M-54.2% | 19.4M-2.5% | 19.9M+57.1% | 12.7M-29.3% | |
| Change in inventory | -1.84M-200.3% | 1.83M+72.1% | 1.07M+889.6% | -135K-122.2% | 609K-77.7% | |
| -39.6M+41.2% | -67.5M-45.3% | -46.4M+67.3% | -142M-41.4% | -100M-4909.9% | ||
| Capital expenditure | 310K-73.1% | 1.15M+269.6% | 312K+81.4% | 172K-42.3% | 298K+14800.0% | |
| Free cash flow | 348M+59.1% | 219M-0.2% | 219M+51.8% | 144M+46.9% | 98.3M+3389.6% | |
| Acquisitions | 0.00 | 0.00-100.0% | 37.0M | 0.00 | 0.00 | |
| -9.05M+17.7% | -11.0M+89.6% | -106M-1642.9% | 6.84M-7.8% | 7.42M-96.5% | ||
| Long-term debt issued | 0.00 | 0.00-100.0% | 200M | 0.00-100.0% | 200M+0.0% | |
| Long-term debt repaid | 16.3M+8.3% | 15.0M+215.8% | 4.75M+137.5% | 2.00M+300.0% | 500K | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 30.0M-77.8% | |
| Common stock repurchased | 0.00 | 0.00-100.0% | 100M | 0.00 | 0.00-100.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 300M+111.9% | 141M+109.7% | 67.4M+611.3% | 9.47M+66.9% | 5.68M-97.2% | |
| Interest paid | 14.7M-15.2% | 17.3M-13.6% | 20.1M+22.5% | 16.4M-17.5% | 19.8M-24.3% | |
| Income taxes paid | 19.8M-75.1% | 79.6M+65.1% | 48.2M+281.4% | 12.6M+339.8% | 2.88M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.16B+9.7% | 1.97B+4.3% | 1.89B-42.1% | 3.27B+30.2% | 2.51B+22.1% | |
| P/E | 13.6×+0.6% | 13.6×+8.1% | 12.5×-40.2% | 21.0×-71.1% | 72.6× | |
| P/S | 2.5×-9.7% | 2.8×-20.9% | 3.5×-57.2% | 8.2×-0.8% | 8.2×-36.2% | |
| P/B | 2.5×-16.9% | 3.0×-23.8% | 3.9×-58.6% | 9.5×-29.4% | 13.5×-36.4% | |
| P/FCF | 6.2×-31.1% | 9.0×-19.3% | 11.2×-46.9% | 21.1×-17.5% | 25.5× | |
| Earnings yield | 7.3%-0.6% | 7.4%-7.5% | 8.0%+67.3% | 4.8%+245.6% | 1.4% | |
| FCF yield | 16.1%+45.0% | 11.1%+23.9% | 8.9%+88.4% | 4.7%+21.3% | 3.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: HRMY’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HRMY filings on SEC EDGAR → Not investment advice.